Gender Dysphoria: Clinical Trials

6 trials for Gender Dysphoria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 terminated. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 3, Unknown 2, Terminated 1

Follow Gender Dysphoria: new trials by email Literature Review of Gender Dysphoria trials Research Report on Gender Dysphoria

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients
17beta Estradiol - Gender Dysphoria
Phase 4TerminatedMaineHealth22022-12-292023-07-27
Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone
Depo-subQ Provera Injectable Product - Gender Dysphoria, Adolescent
Phase 4CompletedUniversity of Colorado, Denver352022-12-062026-02-12
Effect of Nitropaste in Chest Masculinizing Surgery
Nitro-Bid 2 % Topical Ointment - Gender Dysphoria
Phase 4UnknownUniversity of Virginia2562022-08-152024-06-06
The Effect of Pectoral Blocks on Perioperative Pain in Gender Affirmation Top Surgery
Ropivacaine 0.2% Injectable Solution, Saline (0.9%) - Gender Dysphoria, Opioid Use
Phase 4CompletedUniversity of California, San Francisco502020-06-162023-07-03
Effects of Sex Steroids on the Serotonin System
Testosterone, Lynestrenol, Cyproterone Acetate - Gender Dysphoria
Phase 4UnknownMedical University of Vienna922017-02-062018-10-15
Sex Steroids and the Serotonin Transporter
Testolactone undecanoate, Lynestrenol, Cyproterone Acetate - Transsexualism
Phase 4CompletedMedical University of Vienna322010-02-012014-01-03

Narrower conditions

Pain, Postoperative (1)  ·  Transsexualism (1)

Broader conditions

Mental Disorders (6)  ·  Sexual Dysfunctions, Psychological (6)  ·  Behavior (1)  ·  Neurologic Manifestations (1)  ·  Pain (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)  ·  Sexual Behavior (1)  ·  Sexuality (1)  ·  Signs and Symptoms (1)

Interventions

Estradiol (3)  ·  Cyproterone Acetate (2)  ·  Lynestrenol (2)  ·  5-alpha Reductase Inhibitors (1)  ·  DEPO (1)  ·  N,N-dimethyl-4-anisidine (1)  ·  Nitroglycerin (1)  ·  Ointments (1)  ·  Ropivacaine (1)  ·  Sodium Chloride (1)  ·  Testosterone (1)  ·  Triptorelin Pamoate (1)  ·  testosterone undecanoate (1)

Sponsors

Medical University of Vienna (2)  ·  MaineHealth (1)  ·  University of California, San Francisco (1)  ·  University of Colorado, Denver (1)  ·  University of Virginia (1)

Countries

United States (4)  ·  Austria (2)

Top investigators

Esther Kim, MD (1)  ·  Eva M Dindinger, MPH (1)  ·  John T Stranix, MD (1)  ·  Katherine Davis, MD (1)  ·  Rupert Lanzenberger, MD (1)  ·  Rupert Lanzenberger, MD A/Prof (1)

Results publications

PMID 25497691, PMID 37220393, PMID 38216784, PMID 41628614